Herbas VPB

Print
EN | LT
LT - MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES
EN - MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/47 (2013.01)
A61K 31/47 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/4709 (2013.01)
A61K 31/497 (2006.01)
A61K 31/497 (2013.01)
A61K 31/5377 (2006.01)
A61K 31/5377 (2013.01)
C07D 215/38 (2006.01)
G01N 33/5023 (2013.01)
A61P 29/00 (2006.01)
G01N 33/5055 (2013.01)
A61P 1/00 (2006.01)
C12Q2600/158 (2013.01)
A61P 19/02 (2006.01)
C12Q2600/178 (2013.01)
C12Q 1/6883 (2013.01)
A61P 25/00 (2006.01)
G01N 33/50 (2006.01)
C12Q2600/136 (2013.01)
C07D 215/38 (2013.01)
C12Q 1/68 (2018.01)
C07D 401/12 (2013.01)
A61P 1/00 (2018.01)
A61P 1/04 (2018.01)
A61P 11/00 (2018.01)
A61P 11/06 (2018.01)
A61P 17/00 (2018.01)
A61P 17/06 (2018.01)
A61P 19/02 (2018.01)
A61P 21/00 (2018.01)
A61P 25/00 (2018.01)
A61P 25/16 (2018.01)
A61P 25/28 (2018.01)
A61P 29/00 (2018.01)
A61P 35/00 (2018.01)
A61P 37/06 (2018.01)
A61P 9/10 (2018.01)
European patent
(11) Number of the document 3998070
(13) Kind of document T
(96) European patent application number 21211115.7
Date of filing the European patent application 2015-07-17
(97) Date of publication of the European application 2022-05-18
(45) Date of publication and mention of the grant of the patent 2024-12-18
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
14306164 2014-07-17 EP
Inventors
(72)
TAZI, Jamal , FR
NAJMAN, Romain , FR
MAHUTEAU, Florence , FR
SCHERRER, Didier , FR
Grantee
(73) ABIVAX , 7-11 Boulevard Haussmann, 75009 Paris, FR
Centre National de la Recherche Scientifique , 3, rue Michel-Ange, 75794 Paris Cedex 16, FR
Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR
UNIVERSITE DE MONTPELLIER , 163, rue Auguste Broussonnet, 34090 Montpellier, FR
Title
(54) MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES
  MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES